Search

Search Constraints

You searched for: Author/Creator Surmont, Filip

Search Results

2. Early versus late intensification of glucose-lowering therapy in patients with type 2 diabetes: Results from the DISCOVER study. (August 2021)

3. Eligibility of patients with type 2 diabetes for sodium–glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study. Issue 1 (21st March 2019)

4. Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: Insights from the DISCOVER study. Issue 1 (22nd September 2020)

5. Prevalence and impact of respiratory symptoms in a population of patients with COPD in Latin America: The LASSYC observational study. (January 2018)

6. Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study. Issue 7 (July 2020)

7. Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study. Issue 7 (July 2020)

8. Socioeconomic factors associated with hypoglycaemia in patients starting second-line glucose-lowering therapy: The DISCOVER study. (July 2020)

9. Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the global DISCOVER study. (May 2019)

10. Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second‐line therapy: Results from the global DISCOVER study programme. Issue 11 (5th August 2019)